ODTX
Odyssey Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.79
+9.05%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.14x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.17x
- Net debt / EBITDA
- 0.40x
Liquidity & coverage
- Current ratio
- 11.36x
- Quick ratio
- 11.36x
- Cash ratio
- 10.98x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $293.2M
Cash & dividend
- FCF / debt
- -5.26x
- Cash flow / debt
- -5.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026